Viewing Study NCT04293393

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:03 AM
Ignite Modification Date: 2026-02-10 @ 12:30 PM
Study NCT ID: NCT04293393
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-19
First Post: 2020-02-28
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer Patients
Sponsor: Spanish Breast Cancer Research Group
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Early Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Abemaciclib View
None Neoadjuvant View
None HR positive View
None HER2 negative View
None High/intermediate risk View